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The heart is still, by far, the predominant source
of arterial thromboembolism, cited as the site of ori-
gin in 80% to 90% of cases in all reported series.1 An
identifiable noncardiac source of emboli, mostly
downstream embolization of mural thrombus from
aneurysms of the aortoiliac, femoral, or popliteal
arteries, was found in 5% to 10% of patients.2 In the
remaining 5% to 10% of cases, the specific source of
an embolus could not be determined.2
The advent of transesophageal echocardiography
(TEE) and magnetic resonance imaging (MRI) and
the more frequent use of computed tomography
scanning (CT) have led to the identification of mural
aortic thrombi as a source of otherwise unexplained
embolic events, including stroke, transient ischemic
attack, and peripheral emboli. Thus, the incidence of
“cryptogenic” emboli has decreased as diagnostic
modalities have improved.3 Nevertheless, modern
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acute embolic events underwent an extensive diagnostic workup, consisting of TEE, CT,
or MRI, to detect the source of embolization. Patients in whom the heart (n = 51),
occlusive aortoiliac disease (n = 16), or aortic aneurysms (n = 12) was identified as the
source of embolization were excluded.
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eral risk factors for atherosclerosis, but only one young patient had a single risk factor
that promoted thrombosis. Successful percutaneous catheter aspiration embolectomy
was performed in six patients. The remaining two patients underwent surgical thrombo-
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resenting a morbidity of the primary treatment of 25%. MAT of equal value were detect-
ed in the ascending (n = 1) and thoracic aorta (n = 3) by means of TEE, CT, or MRI.
MAT in the abdominal aorta (n = 4) were identified by means of CT and MRI. Surgical
removal of MAT was performed in seven patients by means of graft replacement of the
ascending aorta (n = 1), open thrombectomy of the descending aorta (n = 2), and
thrombendarterectomy of the abdominal aorta (n = 4), without intraoperative or post-
operative complications. No recurrence of MAT occurred during a median follow-up
period of 13 months (range, 4 to 24 months). 
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clinical experience indicates that as many as 40% of
strokes are still of undetermined cause.3
This report details the diagnosis and contrasts the
treatment of eight patients in whom mural aortic
thrombi were diagnosed as a source of embolization.
MATERIAL AND METHODS
In a prospective study from January 1996 to
December 1998, 89 patients with acute arterial throm-
boembolism, referred to the University Hospital of
Bern, underwent an extensive diagnostic workup,
including multiplanar TEE, contrast material-enhanced
spiral CT, and MRI to detect the source of emboliza-
tion. Patients in whom the heart, occlusive aortoiliac
disease, or aortic aneurysms was identified as the source
of embolization were not included in the study. All
patients with a cardiac source of embolization diag-
nosed by means of TEE underwent subsequent CT or
MRI to exclude concomitant mural aortic thrombi.
Patients with mural aortic thrombi underwent screen-
ing for underlying disorders that might promote
thrombosis (homocysteinemia, assays for antithrombin
III, C1 inhibitor, tissue plasminogen activator, plas-
minogen-activator inhibitor-1, anticardiolipin antibod-
ies, proteins C and S deficiency, and the fibrin plate
assay) and were questioned about whether they had a
history of stroke, transient ischemic attack, thrombosis,
or previous peripheral embolization. 
RESULTS
Five female and three male patients, with a median
age of 63 years (range, 35 to 76 years), with emboliza-
tion resulting from mural aortic thrombi were identi-
fied during the study period, representing 9% of all
patients referred with peripheral embolization. In the
remaining 81 patients, the heart (n = 51), occlusive
aortoiliac disease (n = 16), or aortic aneurysms (n =
12) were identified as the most likely sources of
embolization. None of the patients with mural aortic
thrombi had a history of previous thrombotic or
embolic events. The results of screening for diseases
promoting thrombosis in these patients were negative,
except in one patient who had depressed activation of
protein C because of an intermediate hyperhomocys-
teinemia (69 m mol/L), whereas all patients had sever-
al atherosclerotic risk factors (Table I). Four patients
were referred with bilateral and one patient with simul-
taneous peripheral and mild, rapidly regressive clinical
signs of cerebral embolization. Immediate treatment
after admittance consisted of peripheral percuta-
neous catheter aspiration embolectomy in six patients 
and surgical thromboembolectomy in two patients.
Three patients had repetitive distal embolic events
within hours after interventional therapy, despite 
full heparinization and no signs of heparin-induced
thrombocytopenia, requiring reintervention (Table I).
Subsequent below-knee amputation had to be per-
Fig 1. Magnetic resonance imaging of a patient with
peripheral embolic events, revealing a mural aortic throm-
bus (arrow). 
Fig 2. Contrast material-enhanced spiral computed tomog-
raphy of a patient with peripheral embolic events, demon-
strating mural aortic thrombus in the thoracic aorta (arrow).
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formed in two of these patients for irreversible
ischemic tissue damage, thus representing a morbidity
of 25% for the embolic events. Mural aortic thrombi
were detected in the ascending aorta (n = 1) and tho-
racic aorta (n = 3; Figs 1,2) by means of TEE, CT, or
MRI, and in the abdominal aorta (n = 4) by means of
CT or MRI. Regardless of the locale, all mural aortic
thrombi were visualized by means of CT or MRI
(Table II). All patients except one patient, who refused
further therapy and was lost to follow-up, underwent
surgery during the same hospital stay. Surgical therapy
included graft replacement of the ascending aorta on
extracorporeal circulation in hypothermic cardiac
arrest in one patient, posterolateral thoracotomy with
subsequent transaortal thrombectomy of the thoracic
aorta in one patient, and transabdominal thrombecto-
my of the main portion of the descending aorta in a
female patient with simultaneous chronic occlusion of
the celiac trunk and superior mesenteric artery.
Intraoperative TEE was used in these two patients as 
a means of ensuring that the proximal cross-clamp
position was above the thrombus. Transabdominal
endarterectomy of the abdominal aorta was performed
in the remaining four patients. Microscopic sections of
the specimen revealed platelet-fibrin thrombi adherent
to intimal erosions of variable degrees to atheroscle-
rotic plaques with superimposed thrombi. No intraop-
erative or postoperative complications occurred in
these seven patients. During a median follow-up peri-
od of 13 months (range, 4 to 24 months), no recur-
rence of embolization was noted (Table III). All
patients received warfarin postoperatively. Normal-
ization of plasma homocysteine concentration (12
m mol/L) in the patient with hyperhomocysteinemia
occurred within 6 weeks after administration of folic
acid combined with vitamin B12. CT or MRI was per-
formed in all patients, 12 months postoperatively in six
patients, and no recurrence of mural aortic thrombi
was shown (Fig 3).
DISCUSSION
During the past decades, several innovative diag-
nostic and therapeutic techniques have improved the
evaluation of patients for arterial embolism, leading
to a more frequent diagnosis of mural aortic throm-
bi, a heretofore rarely identified source of major
arterial embolism.4-10 The incidence of mural aortic
thrombi, however, remains unknown. In a patho-
logic study, Flory11 reported the presence of mural
thrombi superimposed on atheromatous plaques in
Table I. Patient characteristics, source and site of embolization, risk factors for atherosclerosis, and factors
promoting thrombosis
Age (years); Source of Associated risk factors for Factors promoting
Patient sex embolization Site of embolization atherosclerosis thrombosis
1 63; man Abdominal aorta Lower limbs Hypertension, nicotine use, chronic None
renal failure
2 70; woman Abdominal aorta Lower limbs Hypertension, nicotine use, diabetes None
mellitus
3 32; man Abdominal aorta Lower limbs Hypertriglyceridemia, nicotine use, Depressed activation
hyperhomocysteinemia of protein C
4 70; woman Abdominal aorta Lower limbs Hypertension, nicotine use None
5 67; man Descending aorta Left lower limb Hypertension, nicotine use, hyper- None
cholesterolemia
6 56; woman Descending aorta Recurrent embolization Nicotine use, diabetes mellitus, hyper- None
right lower limb cholesterolemia
7 75; woman Ascending aorta Recurrent embolization Hypertension, nicotine use, diabetes None
upper limb; cerebral mellitus
embolization
8 63; woman Descending aorta Recurrent embolization Hypertension, nicotine use, diabetes None
left lower limb mellitus, hypercholesterolemia
Table II. Diagnostic accuracy of different meth-
ods in patients with aortic mural thrombi
Patient TEE CT MRI
1 — diagnostic not performed
2 — diagnostic not performed
3 — diagnostic not performed
4 — diagnostic not performed
5 diagnostic not performed diagnostic
6 diagnostic not performed diagnostic
7 diagnostic not performed diagnostic
8 diagnostic not performed diagnostic
TEE, Transesophageal echocardiography; CT, computed tomog-
raphy; MRI, magnetic resonance imaging.
The therapy for intraaortic thrombi remains unde-
fined, although there is evidence that patients with
the finding of protruding thrombi of the aorta have a
high risk of subsequent vascular events.15 Thus, ther-
apy for these patients should focus on preventing the
evolution of mobile lesions and provide protection
against the embolic potential of these lesions. Drug
therapy to lower blood lipids or calcium antagonists,
currently applied to reduce atheromatous growth in
the coronary arteries, may eventually reduce such
lesions.16 Anticoagulation may be administered to
patients whose atheromas have mobile components,
because these components have been proven to be
thrombi in a small number of patients and have been
noted to disappear during anticoagulation therapy.17
Moreover, even complete resolution of mural aortic
thrombi with continuous warfarin therapy has been
described in a small number of patients.18 However,
the risk-benefit ratio for simple anticoagulation thera-
py needs further evaluation. In addition to the widely
known complications of anticoagulation therapy,
bleeding into atherosclerotic plaques with plaque rup-
ture and cholesterol embolization have been
described.19,20 Furthermore, anticoagulation therapy
may inhibit the protective fibrin layer over an eroded
or ulcerated aortic plaque and interfere with the
cementing of cholesterol and atheromatous debris by
fibrin, thus causing repetitive embolization.21 The
value of antithrombotic agents (ie, aspirin, ticlopi-
dine) or thrombolysis has not been determined yet. In
a single case, successful thrombolysis of an aortic arch
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the aorta in six of nine patients who had arterial
embolization and severe atherosclerotic plaques on
autopsy. More recently, Machleder et al4 reported an
incidence of 0.45% of nonaneurysmal aortic mural
thrombus in 10,671 consecutive autopsies, with 17%
of these patients having evidence of distal emboliza-
tion. The true incidence, however, has to be signifi-
cantly higher, because it is not uncommon for these
mobile components to disappear because of sponta-
neous or postmortem intrinsic thrombolysis or
because they break loose and embolize. 
The pathogenesis of aortic mural thrombus for-
mation has not been defined yet, although it differs
distinctly from atheroembolism, encompassing a
spectrum of severity ranging from thrombus adher-
ent to a macroscopically near-normal aortic wall to
that found in large superficial intimal erosions and
multiple areas of large ulcerated atherosclerotic
plaques, known as “shaggy” aorta.12 Generalized
hypercoagulation or vascular endothelial disorder has
been proposed to be the most important etiological
factor for aortic mural thrombus formation.4 The
results of screening for thrombosis-promoting disor-
ders were negative, except in the case of one young
patient. Additionally, all patients had single thrombi,
and there was no concurrent appearance with a car-
diac thrombus. Conversely, all patients had several
risk factors for atherosclerosis, suggesting that forma-
tion of mural aortic thrombi, in most cases, is pri-
marily a localized problem of the aortic wall.
The development and subsequent refinement of
TEE has made possible the relatively noninvasive, clear
visualization of the aortic arch and the descending
aorta. This procedure can safely be done at the bed-
side, while patients are awake, and with a very low risk
for complications.3 Several studies with TEE have
clearly demonstrated the association between protrud-
ing atheromas of the transverse aortic arch and neuro-
logical events.7-10 Nonetheless, TEE has some disad-
vantages, because portions of the aortic arch and the
abdominal aorta are not visualized. Additionally, the
investigation is not pleasant for most patients, because
the local anesthetic spray often wears off toward the
end of long investigation and respraying with the
probe in situ is difficult. In contrast, MRI is usually
well tolerated and is superior to TEE as a means of
defining extracardiac structures.13 Furthermore, MRI
and spiral CT have been shown to be more sensitive
than TEE as a means of detecting the formation of
thrombus in the entire thoracic aorta.14 Consequently,
we suggest that CT or MRI is the ideal tool for the
diagnosis, exact localization, and definition of the
extent of mural aortic thrombi. 
Fig 3. Magnetic resonance imaging of the patient shown
in Fig 2 6 months after transaortal thrombectomy, show-
ing no recurrence of the mural aortic thrombus.
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thrombus in a patient after mesenteric embolism was
described.22 This therapy bears the potential danger
that thrombolytic agents could selectively lyse the
stalk of pedunculated lesions, releasing the bulk of the
lesions into the bloodstream, and thus causing mas-
sive embolization. 
Surgical therapy (ie, aortic endarterectomy) has
been performed successfully in selected patients.23,24
Antiplatelet agents or warfarin was used postoperative-
ly in these patients, and no recurrence of embolization
occurred during follow-up. Similarly, no recurrence of
embolization occurred in our patients during a medi-
an follow-up period of 13 months. However, the exact
risks and long-term results of this procedure are not
yet known. The indications for a surgical treatment
and the short- and long-term effects of this treatment,
compared with those of anticoagulation therapy, have
to be evaluated. The principle features of surgical ther-
apy aim to normalize the aortic surface, by means 
of graft replacement, thrombectomy, or segmental
endarterectomy. Increasing experience and sophistica-
tion of equipment favors endovascular techniques for
specific vascular lesions, such as floating aortic plaques,
which can be managed successfully with stent insertion
to prevent further peripheral embolization.25 In our
patients with mural aortic thrombi, we felt that stent
insertion was too hazardous, first because of the large
size of the mural thrombi and second because of the
impending risk of embolization during endovascular
therapy.
In summary, mural aortic thrombi are an impor-
tant cause of distal embolization and may represent
a relevant segment of the cryptogenic sources of
arterial embolization. The technique of choice for
the diagnosis of this condition is CT or MRI.
Surgical treatment (ie, thrombectomy, endarterecto-
my, or graft replacement of the involved aortic seg-
ment) is recommended in selected patients. The role
of simple anticoagulation or thrombolytic therapy
still awaits further evaluation.
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